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OCA-B was originally identified as a nuclear
transcriptional coactivator that is essential for
antigen-driven immune responses. The later
identification of a membrane bound, myristoy-
lated form of OCA-B suggested additional,
unique functions in B cell signaling pathways.
This study has shown thatOCA-Balso functions
in the pre-B1-to-pre-B2 cell transition and,most
surprisingly, that it directly interacts with SYK,
a tyrosine kinase critical for pre-BCR and BCR
signaling. This unprecedented type of interac-
tion—a transcriptional coactivatorwith a signal-
ing kinase—occurs in the cytoplasm and di-
rectly regulates SYK stability. This study
indicates that OCA-B is required for pre-BCR
and BCR signaling at multiple stages of B cell
development through its nontranscriptional reg-
ulation of SYK. Combined with the deregulation
ofOCA-B target genes, thismayhelp explain the
multitude of defects observed in B cell develop-
ment and immune responses ofOca-b/mice.
INTRODUCTION
OCA-B (OBF-1/BOB1) is a B cell-specific coactivator that
acts in conjunction with the octamer binding transcription
factors OCT-1 and OCT-2. Initial studies revealed a re-
quirement for OCA-B, through OCT-1/2 at the octamer el-
ement (50-ATGCAAAT), for optimal immunoglobulin (Ig)
gene promoter activity in vitro (Luo et al., 1992; reviewed
in Luo and Roeder, 1999). Subsequent studies with Oca-
b-deficient (Oca-b/) mice showed that OCA-B plays
a broad role in B cell development and function (Kim
et al., 1996; Schubart et al., 1996; Nielsen et al., 1996).
Surprisingly, IgM expression is largely normal in Oca-b/
mice, although OCA-B is required for full activity of a sub-
set of k light-chain promoters (Casellas et al., 2002). Thereis also a reduction in the transitional B cell compartment in
the spleens ofOca-b/mice, perhaps as a consequence
of the skewed Igk repertoire and/or a B cell signaling de-
fect (Casellas et al., 2002; Jankovic and Nussenzweig,
2003).
Themost drastic defect inOca-b/mice is observed in
the peripheral lymphoid organs during antigen-dependent
B cell maturation and effector function. These defects in-
clude dramatically diminished levels of IgH secondary iso-
types, a complete lack of germinal centers, and impaired
antibody responses to both T-independent and T-depen-
dent antigens (Kim et al., 1996; Schubart et al., 1996; Niel-
sen et al., 1996). The reduction in secondary-isotype
levels is caused by reduced expression of the switched
genes and may be attributed in part to OCA-B function
at the 30 enhancer (Kim et al., 1996; Tang and Sharp,
1999; Stevens et al., 2000). At the cellular level, Oca-b/
B cells are deficient in processing B cell antigen receptor
(BCR) derived signals, as evidenced by their reduced pro-
liferation following BCR ligation (Kim et al., 1996). A recent
study has identified additional OCA-B target genes that
may be involved in these processes (Kim et al., 2003), al-
though the exact mechanisms by which these genes con-
tribute to B cell signaling and differentiation are not fully
understood. Additionally, OCA-B is likely to play a unique
role in B cell signaling, as evidenced by the presence of
two distinct OCA-B isoforms, one that is predominantly
nuclear and another that is myristoylated and present in
the cytoplasm (Yu et al., 2001).
Given that Oca-b/ B cells are deficient in BCR signal-
ing, it seemed important to determine whether these cells
have a similar phenotype relative to pre-BCR signaling
since both pathways involve the action of many of the
same proteins, such as SYK, PLCg2, FYN, BLK, LCK,
and LYN (reviewed in Wang and Clark, 2003). Further-
more, Igb, which is the signaling component of both the
pre-BCR and BCR, has been identified as an OCA-B tar-
get gene in mature B cells (Malone and Wall, 2002). Addi-
tionally, and significantly, the signaling proteins BTK and
SLP-65, which are also critical for BCR signaling and ma-
ture B cell differentiation, have recently been shown toCell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc. 761
play a role in early B cell development as well (Middendorp
et al., 2002; Flemming et al., 2003).
In the current study, an analysis of early B cell surface
marker expression and proliferative capacity of Oca-b/
bone-marrow B cells has revealed defects in the pre-B1-
to-pre-B2 cell transition, in pre-BCR signaling, and in IL-
7 responsiveness. Levels of expression of recently identi-
fied OCA-B target genes, as well as genes involved in
pre-BCR signaling, have also been determined in order
to access possible contributions to the observed pheno-
type. This analysis has revealed a severe reduction of the
SYK protein level in both early and mature B cells from
Oca-b/ mice and, surprisingly, a direct interaction be-
tween SYK and OCA-B. This interaction is particularly
unique and indicates a mechanism by which OCA-B,
a conventional nuclear transcription coactivator, can also
act through SYK, a tyrosine kinase.
RESULTS
OCA-B Controls Early B Cell Development
In mouse bone marrow, developmental progression from
the pro-B (B220+/CD43+) to the pre-B (B220+/CD43)
cell stage was associated with a dramatic increase in
the level of OCA-B protein (Figures 1A and 1B). Further-
more, the expression levels of OCA-B during B cell devel-
opment correlated directly with the RNA expression levels
of known OCA-B target genes such as Cdc37, Cyclin D3,
Kcnn4, and Lck (Figure 1C). These findings suggested that
increased OCA-B expression during early stages of B cell
development may contribute to establishment of the gene
expression program required for pro-B-to-pre-B cell
development.
In an analysis of B cell populations in the bone marrow,
Oca-b/ mice showed reduced frequencies and num-
bers of pre-B2 (B220+/CD43/CD25+) cells (Figure 1D).
In contrast, the OCA-B deficiency led to an increase in
pre-B1 (B220+/CD43+/CD25) cells (Figure 1D). Consis-
tent with an increased proportion of B220+/CD43+ pre-B
cells in Oca-b/ mice, there was also a significant in-
crease both in the number of large cells (on average
25%; p = 0.018) within the bone marrow and in the
B220+ compartment (p = 0.012) (Figure 1E). Defective
pre-B cell development in the bone marrow of Oca-b/
mice was accompanied by reduced cellularity of the pe-
ripheral B cell compartment and significantly diminished
numbers of B cells that recirculate to the bone marrow
from the periphery (Figure 1D; Hess et al., 2001). Overall,
these findings demonstrate an important role of OCA-B
in the pre-B1-to-pre-B2 cell transition and/or in pre-B
cell expansion.
OCA-B Target Genes Show Reduced Expression
in Oca-b/ Early B Cells
It is possible that reduced expression of these genes in
Oca-b/ mice may contribute to the observed develop-
mental block. To examine this issue, pre-B1 (CD19+/
CD43+/CD25) and pre-B2 (CD19+/CD43/CD25+) cells762 Cell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc.were sorted and the RNA expression levels of relevant
genes were analyzed by qPCR (Figure 2A). As expected
(Hendriks and Middendorp, 2004), the surrogate light-
chain genes Vpre-B and l5 were more highly expressed
in pre-B1 cells whereas Iga, Igb, and Cdc37 were more
highly expressed in pre-B2 cells (Figures 2B and 2C). Fur-
ther analysis of wild-type versus Oca-b/ cells showed
that Oca-b/ cells had significantly reduced expression
(shown as negative values) of two OCA-B target genes,
Igb and Lck, that are involved in B cell signaling mecha-
nisms (Figure 2D). These results are consistent with the
possibility of OCA-B function in early B cell development
through regulation of its target genes. Importantly, espe-
cially in light of additional findings (below), the RNA levels
for other kinases involved in B cell signaling (BTK, LYN,
FYN, and SYK) were relatively unaffected by the OCA-B
deficiency (Figure 2D).
Oca-b/ Early B Cells Aberrantly Respond
to Differentiation Signals
Although some alterations in the RNA expression levels of
a number of relevant genes were observed, it remained
possible that Oca-b/ mice have additional defects in
early B cell signaling. Importantly, phenotypes similar to
those observed for Oca-b/ mice also have been de-
scribed forSlp-65 /,Btk/, and Irf4//Irf8/mice (Ju-
maa et al., 1999; Middendorp et al., 2002; Flemming et al.,
2003; Lu et al., 2003). BTKandSLP-65play important roles
in pre-BCR signaling, as evidenced by impaired pre-BCR-
mediated responses inBtk/ andSlp-65/ cells cultured
in the presence of IL-7 (Jumaa et al., 1999; Middendorp
et al., 2002; Flemming et al., 2003). Providing IL-7 to
ex vivo cultured CD19+ cells from bone marrow stimulates
proliferation of IL-7Ra-bearing pro-B cells. In vivo, IL-7 is
provided by stromal cells and serves to drive proliferation
of IL-7Ra-bearing B cells. Furthermore, the pre-BCR and
IL-7Ra signaling pathways are tightly linked in that pre-
BCR signaling is known to limit IL-7 responsiveness by
promoting light-chain rearrangement and differentiation
(Marshall et al., 1998; Hendriks and Middendorp, 2004).
In order to further examine signaling in Oca-b/ mice,
we made use of the IL-7 culture system that had been
used to study the Btk/ and Slp-65/ mice. Total
bone-marrow B cells (CD19+) were isolated and cultured
for a time course that extended to 168 hr of IL-7 exposure.
In this culture system, IL-7-responsive cells typically be-
come larger in size, and this response was essentially nor-
mal in the Oca-b/ cultures (data not shown). Consistent
with the high level of OCA-B expression in noncultured
pre-B cells (Figure 1D), OCA-B was also expressed
throughout the IL-7 time course (Figure 3A). Strikingly,
the Oca-b/ pre-B cells were found to be markedly hy-
perproliferative, relative to their wild-type counterparts,
in the presence of IL-7 (Figure 3B). A similar phenotype
also was observed in long-term stromal cell-dependent
Oca-b/ bone-marrow cultures (data not shown). An ad-
ditional analysis of cell surfacemarker expression showed
an increased percentage of cells expressing the pre-BCR
Figure 1. Oca-b/ Mice Have an Altered Distribution of Bone-Marrow B Cells
(A) Bone-marrow B cells from Oca-b+/+ mice were sorted based on surface expression of B220 and CD43.
(B) Immunoblot for OCA-B using whole-cell extract from fractions sorted in (A).
(C) Expression of OCA-B target genes examined by RT-PCR. Total bone-marrow cells were prepared prior to sorting. (A)–(C) are representative of four
experiments.
(D) Cellular populations from Oca-b+/+ and Oca-b/ bone marrow were analyzed by flow cytometry using antibodies against the indicated cell sur-
face markers. The numbers within the gates are percentages of live cells (low SSC). Data are representative of three experiments.
(E) Size analysis of live cells (left) or B220+ cells (right) from bone marrow of Oca-b+/+ (solid) or Oca-b/ (dashed) mice.in the Oca-b/ population after 48 hr of IL-7 exposure
(32.3% versus 52.6%) (Figure 3C). As expected, CD43
and the pre-BCR were coexpressed on the cell surface,
indicating the specificity of the pre-BCR antibody (Fig-ure 3C). Since pre-BCR signaling is known to limit IL-7-
mediated proliferation (Marshall et al., 1998), these results
show that Oca-b/ pre-B cells have compromised pre-
BCR signaling.Cell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc. 763
Figure 2. Expression Levels of Critical Genes for Pre-B Cell Signaling in Oca-b/ Mice
(A) Pre-B cells were sorted based on expression of CD19, CD43, and CD25.
(B and C) qPCR was performed. The values shown are fold changes calculated by relative quantification using Gapdh to compare RNA levels in pre-
B1 versus pre-B2 cells for each genotype using the equation ratio = (Etarget)
DCT(Oca-b+/+preB1-Oca-b+/+preB2)/(EGAPDH)
DCT(Oca-b+/+preB1-Oca-b+/+preB2).
Genes that are induced in pre-B1 cells and pre-B2 cells are shown in (B) and (C), respectively. The values shown are averages generated from three
to five independent experiments. Error bars represent standard deviations.
(D) A similar method was used to determine the difference in expression of these genes between Oca-b+/+ and Oca-b/ cells using the equation
ratio = (Etarget)
DCT(Oca-b+/+preB1-Oca-b/preB1)/(EGAPDH)
DCT(Oca-b+/+preB1-Oca-b/preB1) for each cell stage. A negative value denotes that Oca-b/ cells
have fewer transcripts relative to wild-type cells. The values shown are averages generated from three to five independent experiments. ND, not
determined.Oca-b/ Pre-B Cells Exhibit Reduced
Pre-BCR-Mediated Differentiation
Given that the Oca-b/ pre-B cells have defective pre-
BCR signaling and that this signaling pathway promotes
immunoglobulin light-chain rearrangement and surface
expression, we analyzed the latter process in Oca-b/
cells. IL-7 removal in this culture system serves to pro-
mote rearrangement of the immunoglobulin light chain
(Igk), and this can be used to determine whether pre-
BCR signaling is functional (Rolink et al., 1991; Ray
et al., 1998). As previously reported (Hess et al., 2001),
there were fewer IgM+/Igk+ cells at t = 0 in Oca-b/
mice as a result of a reduction in the recirculating B cell
pool (Figure 3D). As expected, by 52 hr post-IL-7 removal,
the wild-type culture had reestablished a m+/k+ population
(10%) (Figure 3D). This differentiation step did not occur
(within the given time period) in the rapidly proliferating764 Cell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc.Oca-b/ culture such that, at 52 hr post-IL-7 removal,
only 0.6% of live Oca-b/ cells were m+/k+ (Figure 3D).
A failure to produce surface k+ cells upon removal of IL-
7 from the Oca-b/ cells further indicates that OCA-B is
involved in pre-BCR signaling.
In light of the similar phenotypes of Oca-b/, Btk/,
and Slp-65/ mice, our demonstration that OCA-B plays
a role in pre-BCR signaling, and a block in early B cell de-
velopment of Syk/ mice (Cheng et al., 1995; Turner
et al., 1995; Saijo et al., 2003), we examined Syk/ cells
in the IL-7 culture. For this analysis, we used Syk condi-
tional knockout (Syk/) mice that had been generated
using Cre-mediated recombination (Saijo et al., 2003).
Interestingly, Syk/ cells also were hyperproliferative in
response to IL-7 (Figure 3B). Altogether, these results sug-
gest that OCA-B might function in pre-BCR signaling
through a mechanism involving SYK, BTK, or SLP-65.
Figure 3. Altered Response of Oca-b/ B Cells to IL-7
(A)Whole-cell extracts fromOca-b+/+CD19+ cells cultured with IL-7were prepared at the indicated time points. The CD19+ extract was prepared after
sorting but prior to IL-7 culture. After IL-7 removal, the culture was continued for 52 hr. OCA-B expression was monitored by immunoblot.
(B) CD19+ cells were isolated from bone marrow of Syk+/+, Syk/, Oca-b+/+, or Oca-b/ mice and cultured with media containing IL-7 for up to 7
days. Live cells were counted using trypan blue exclusion to measure proliferation during the time course. Each point represents the average fold
increase for three mice. Error bars represent standard deviations.
(C) Surface expression of the pre-BCR during the time course was analyzed by flow cytometry; the 48 hr time point of IL-7 exposure is shown. The
values shown are percentages of live cells within the pre-BCR+/CD43+ gate and are averages of three representative experiments.
(D) CD19+ cells were isolated from bone marrow of Oca-b+/+ or Oca-b/ mice and cultured with media containing IL-7 for up to 142 hr. After IL-7
removal, the culture was continued for 52 hr. Igk+ cells were monitored in three independent experiments, and the percentages of cells within the
gates shown were averaged to generate the values shown.Pre-BCR Signaling Is Compromised
in Oca-b/ Cells
In order to determine the mechanism by which OCA-B
functions in pre-BCR signaling, we directly measured
pre-BCR signaling capacity in CD19+ bone-marrow cells
that were cultured in IL-7 for 48 hr to allow accumulation
of pre-BCR+ cells (30%–50% CD19+/CD43+/SL-156+)
(Figure 3D). To avoid crosslinking themature BCR, k+ cells
were depleted after 48 hr of IL-7 culture. Flow cytometry
analysis of the depleted population confirmed a near ab-
sence of mature cells (98% purity; data not shown). The
pre-BCR was then crosslinked, and, as expected, pre-
BCR signaling measured by global tyrosine phosphoryla-
tion peaked at 2 min in the wild-type samples (Figure 4A,upper panel). Crosslinking of the Oca-b/ cells resulted
in greatly reduced tyrosine phosphorylation, suggesting
a possible reduction in expression and/or activity of pro-
tein tyrosine kinases (Figure 4A, upper panel). Remark-
ably, we found that the SYK protein level was severely
reduced in Oca-b/ pre-B cells even in the absence of
pre-BCR activation (Figure 4A, lower panel). The expres-
sion of LCK, the product of an OCA-B target gene, also
was reduced, albeit less dramatically, while FYN and
ERK expression levels were unaffected (Figure 4A, lower
panel). A significant reduction of SYK expression was
also apparent in freshly isolated pre-B cells, indicating
that the reduction in SYK expression is not a by-product
of culture in IL-7 (Figure 4C).Cell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc. 765
Figure 4. Analysis of Pre-BCR Function and SYK Expression in Oca-b/ Cells
(A) Bone-marrowCD19+ cells were isolated and cultured in IL-7 for 48 hr. After depletion of k+ cells, the pre-BCRwas crosslinked for various lengths of
time. Tyrosine phosphorylation in the cellular extract was monitored (pTYR). The band corresponding to phospho-SYK is labeled. The total protein
levels of SYK, LCK, ERK, FYN, OCA-B, and actin were also examined. The data are a representative set from four experiments.
(B) qPCR was used to analyze SYK RNA levels in the cells that were used for the experiment in (A). Relative quantification was used to compare the
genotypes, and a negative value denotes fewer transcripts inOca-b/ cells. The values shown are averages generated from three experiments. Error
bars represent standard deviations.
(C) Pre-B cells were sorted based on expression of CD19, CD43, and CD25. Immunoblotting was performed for SYK, LCK, actin, and ERK. The data
are representative of two experiments.
(D–F) Total B cells were isolated from the spleens of Oca-b+/+ or Oca-b/ mice. The cells were activated in culture with anti-IgM (D); anti-IgM, anti-
CD40, and IL-4 (E); or LPS (F) for up to 120 hr. Expression of SYK, phosphorylated SYK at tyrosine 317 (SYKpY317), and ERK were analyzed by
immunoblot. The activation experiments were performed three times.
(G) Resting B cells were isolated from spleens ofOca-b+/+ orOca-b/mice and activatedwith anti-IgM for up to 24 hr in either the presence (+CHX) or
absence (CHX) of cycloheximide. The stabilities of SYK and ERK were monitored by immunoblot.766 Cell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc.
Because OCA-B is primarily known for its role in tran-
scription, it was of interest to determine whether the
SYKRNA level is also affected in the IL-7 cultured cells. In-
terestingly, qPCR indicated that the SYK RNA level was
reduced only marginally (2.9-fold), relative to the SYK pro-
tein level, after 48 hr of culture (Figure 4B). This coincides
with the moderate reduction (2.6-fold) observed in freshly
isolated pre-B cells (Figure 2D). Although two nonconsen-
sus octamer sites were identified in the predicted Syk pro-
moter region, occupancy of these sites by OCT or OCA-B
was not observed in IL-7-cultured primary cells or in the
murine lymphoblastic A20 cell line by chromatin immuno-
precipitation assays (data not shown). Given that the these
assays were negative and that qPCR showed a very mar-
ginal difference in SYK RNA levels in vivo (Figure 2D and
Figure 4B), we conclude that Syk is not a transcriptional
target of OCA-B.
OCA-B Directly Regulates SYK Protein Stability
Initial studies of Oca-b/mice focused on the character-
ization of OCA-B function in mature B cells. Oca-b/
mice have compromised tyrosine phosphorylation, cal-
cium flux, and proliferation in response to BCR stimula-
tion. Additionally, these mice have compromised re-
sponses to T-dependent antigens (reviewed in Teitell,
2003). To explore the possibility that reduced SYK protein
levels inOca-b/mice might contribute to these defects,
splenic B cells were isolated and cultured for up to 120 hr
with anti-IgM (BCR stimulation); anti-IgM, anti-CD40, and
IL-4 (costimulation to mimic T cell-dependent signaling);
or LPS (Figures 4D–4F). Analysis of the SYK expression
levels by immunoblot revealed marked reductions in the
SYK protein level for all of the activation conditions tested
(Figures 4D–4F). In contrast, the protein levels of other ki-
nases such as LYN, FYN, and ERK were not affected by
the OCA-B deficiency (Figures 4D–4F and data not
shown). Importantly, SYK is dynamically regulated in the
wild-type cells that have received costimulation (Fig-
ure 4E), which is consistent with this type of stimulation
promoting proliferation and differentiation as opposed to
proliferation alone during stimulation with anti-IgM or
LPS. These data indicate that the specific reduction of
SYK protein is likely to contribute to the reduced respon-
siveness of Oca-b/ mice to BCR stimulation and
T-dependent antigens.
Since the SYK protein level was affected at multiple
stages of B cell development (early and peripheral B cells)
and because Syk is not a transcriptional target of OCA-B,
it was necessary to consider alternative mechanisms by
which OCA-B could regulate SYK. Importantly, SYK is
heavily regulated at the level of protein stability through
proteasome-dependent pathways in many hematopoietic
cell types (reviewed in Rao et al., 2002). To initiate ubiqui-
tin-mediated degradation, SYK is tyrosine phosphory-
lated at residue 317 by LYN, which then allows SYK to
be targeted by the E3 ubiquitin ligase CBL-B (reviewed
in Rao et al., 2002). To explore the possibility that OCA-
B may affect SYK protein levels through this degradationpathway, the level of SYK that is phosphorylated at resi-
due 317 was examined. Indeed, there was a significant in-
crease of this formof SYK in theOca-b/ cells (Figure 4D).
The increased phosphorylation at this site in mature B
cells from Oca-b/mice indicates that SYK is less stable
in the absence of OCA-B. In order to confirm that the alter-
ations in SYK protein levels inOca-b/mature B cells are
a direct result of reduced SYK protein stability, we ana-
lyzed SYK degradation in resting B cells cultured in the
presence of cycloheximide and anti-IgM (Figure 4G). Anal-
ysis of SYK protein levels by immunoblot indicated that
SYK is highly unstable in Oca-b/ cells relative to wild-
type cells (Figure 4G).
Because OCA-B directly regulates SYK protein stability,
it is important to note that B cells contain two OCA-B iso-
forms that arise from different translation start sites (Yu
et al., 2001). The larger form, p35, is myristoylated and is
localized predominantly to the cytoplasm and plasma
membrane (Yu et al., 2001); therefore, it is plausible that
OCA-B and SYK could interact in the cytoplasm or at
the membrane. To investigate this possibility, we per-
formed immunofluorescence microscopy to determine
whether OCA-B and SYK colocalize. Namalwa cells, a hu-
man Burkitt’s lymphoma B cell line, were used for these
experiments. The localization of IgM, SYK, and OCA-B
was analyzed over a time course of anti-IgM stimulation
or anti-IgM, anti-CD40, and IL-4 costimulation. Analysis
of IgM fluorescence after anti-IgM stimulation showed
a characteristic aggregation of IgM, and, as expected,
SYK and IgM also colocalized to the membrane (Fig-
ure 5A). Furthermore, colocalization of OCA-B and IgM
was frequently observed upon stimulation with anti-IgM
or anti-IgM, anti-CD40, and IL-4 (Figures 5A and 5B). Inter-
estingly, a significant number of cells (p = 0.0057) showed
a strong cytoplasmic localization of OCA-B by the end of
the anti-IgM stimulation time course (Figure 5C, blue).
There was also a significant increase of cells with OCA-
B in this configuration during costimulation (Figure 5B);
however, the change in localization was more rapid, oc-
curring within 10 min (p = 0.004) (Figure 5C, red). Colocal-
ization of SYK and OCA-B could be observed in cells that
had strong cytoplasmic staining of OCA-B (Figure 5A and
5B). Interestingly, some of the cells showed both nuclear
and cytoplasmic staining for SYK (Figure 5A). This corre-
lates with the finding that Namalwa nuclear extracts
have a significant amount of SYK, as detected by immu-
noblot (data not shown). Similar results were also obtained
by imaging Daudi cells, another Burkitt’s lymphoma cell
line (data not shown).
OCA-B and SYK Interact Directly
To confirm that the observed colocalization of SYK and
OCA-B represents a protein-protein interaction, we per-
formed immunoprecipitation experiments with whole-cell
extracts from Oca-b+/+ splenocytes that had been stimu-
lated with anti-IgM for up to 5 hr. SYK was immunoprecip-
itated with OCA-B at t = 0 and showed an increased level
of coimmunoprecipitation that was coincident withCell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc. 767
Figure 5. Analysis of Subcellular Localization of IgM, SYK, and OCA-B by Immunofluorescence Microscopy
(A) Namalwa cells were stimulated with anti-IgM for 120 min (t = 120) or left unstimulated (t = 0), after which the localizations of IgM (red), OCA-B
(green), and SYK (green) were analyzed. To show colocalization, the red and green channels were merged (merge). DAPI was used for nuclear stain-
ing. The data are representative of three experiments.
(B) Namalwa cells were stimulated with anti-IgM, anti-CD40, and IL-4 for up to 120 min or left unstimulated (t = 0) and imaged as in (A). t = 10 min
is shown.
(C and D) The occurrence of cells with cytoplasmic staining of OCA-B (as visualized by immunofluorescence microscopy) during a time course of
stimulation is presented. For each time point, 600 cells were scored for the presence of either nuclear and cytoplasmic (C) or mainly cytoplasmic
(D) staining for OCA-B. Anti-IgM stimulation is shown in blue; anti-IgM, anti-CD40, and IL-4 costimulation is shown in red. Counting was performed
for three independent experiments. The error bars are standard deviations based on averaging the number of cells counted.increased tyrosine phosphorylation for up to 10 min
(Figure 6A). By 2 hr, the amount of SYK associated with
OCA-B was roughly back to that of the resting state (t = 0)
(Figure 6A). Because SYK expression is reduced in
Oca-b/ mature B cells that have been activated in cul-
ture for long periods of time, the interaction between
OCA-B and SYK was analyzed in the context of longer
costimulationwith anti-IgM, anti-CD40, and IL-4. Immuno-
blot analysis of the derived extracts revealed that the in-
teraction decreased between 5 and 65 hr of activation.
Thus, by 40 hr, the association of SYK and OCA-B was
marginal compared to t = 0, and by 65 hr, SYK protein
was no longer present in the immunoprecipitate768 Cell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc.(Figure 6B). The dramatic induction of OCA-B expected
at later time points of costimulation (Kim et al., 2003) also
was observed.
In order to determine whether the interaction between
SYK and OCA-B is direct, we performed GST-pull-down
experiments using bacterially expressed GST-OCA-B fu-
sion proteins and bacterially expressed His-tagged full-
length SYK. GST-OCA-B fusion proteins were purified
and normalized for the pull-down according to the amount
of full-length product (Figure 6C). The pull-down showed
a direct interaction between SYK and OCA-B, with SYK
having the highest affinity for the C terminus of OCA-B
(Figure 6D), indicating that SYK protein stability is
regulated by direct interaction with the OCA-B transcrip-
tional activation domain.
Since OCA-B and SYK are colocalized in the cytoplasm
after stimulation with anti-IgM or anti-IgM, anti-CD40, and
IL-4 (Figures 5A and 5B), it was of interest to determine
whether SYK preferentially associates with OCA-B p35,
the myristoylated form, relative to OCA-B p34. Ni-NTA
pull-down assays were performed using His-tagged full-
length SYK and either whole-cell (WCE), cytoplasmic
(S100), or nuclear (NE) extracts from Namalwa cells.
Full-length SYK was able to pull down both forms of
OCA-B with relatively equal efficiencies (Figure 6E). These
data are consistent with a strong OCA-B interaction with
SYK through a C-terminal domain that is the same for
both forms of OCA-B.
Given the reduced nuclear staining of OCA-B in Na-
malwa cells upon stimulation (Figure 5C), the interaction
between OCA-B and SYK was analyzed by anti-OCA-B
immunoprecipitation with whole-cell extracts from anti-
IgM-stimulated Namalwa cells. This analysis revealed an
increased OCA-B-SYK association that correlated with
the increase in cytoplasmic OCA-B (Figure 6F, upper
panel). Interestingly, an immunoblot for phosphotyrosine
revealed that phosphorylated SYK does not coimmuno-
precipitate with OCA-B (Figure 6F, pTYR, lower panel).
Importantly, this indicates that SYK has not yet been
phosphorylated by BCR signaling when it interacts with
OCA-B. To examine the interaction between OCA-B and
SYK in more detail, the SYK domain that interacts with
OCA-B was mapped. His-tagged SYK proteins were gen-
erated in a manner consistent with the domains of SYK.
Other than full-length SYK, only SYK fragments containing
the kinase domain are able to efficiently pull down both
forms of OCA-B from cytoplasmic extracts (S100) (Figures
6E and 6G). Of the kinase-domain-containing SYK frag-
ments, those containing the C-terminal portion of the
kinase domain are able to interact with OCA-B most effi-
ciently (Figure 6G).
Although both isoforms of OCA-B are able to interact
with SYK in vitro (Figure 6), it remains possible that there
could be preferential association of one form with SYK
in vivo. To address this possibility, BAC-transgenic mice
that specifically express OCA-B/p35 or OCA-B/p34 in B
cells were generated on the Oca-b/ background. In
this way, loss of function of one form can be assessed us-
ing BAC clones in which the OCA-B locus has been genet-
ically modified by introducing point mutations in one of the
two translation start sites. We have confirmed that the
transgenic mice obtained have the expected pattern and
selectivity of OCA-B expression (data not shown). To ex-
amine SYK regulation in thesemice, CD19+ cells were har-
vested from bone marrow and cultured in the presence of
IL-7 (Figure 7). All of the transgenes (TgOca-b, Tgp34, and
Tgp35) were able to rescue the hyperproliferation defect
of Oca-b/ mice (Figure 7A). Consistent with the in vitro
interaction data, the OCA-B p34 and p35 transgene prod-
ucts were both able to stabilize SYK in Oca-b/ mice
(Figure 7B).DISCUSSION
Role of OCA-B in Early B Cell Differentiation
and Pre-BCR Signaling
The finding that a substantial fraction of cellular OCA-B is
localized to the cytoplasm and membrane (Yu et al., 2001)
strongly suggests that OCA-B has multiple roles in the cell
and can function in processes other than transcription.
The identification of a novel interaction between OCA-B
and SYK supports this notion and has the potential to ex-
plain many aspects of the Oca-b/ phenotype—includ-
ing the defects in early B cell development that are pre-
sented in this study. Early B cell development is marked
by characteristic changes in cellular phenotype that are
regulated by a series of antigen-independent checkpoints
mediated by cell signaling pathways and dependent on
the successful rearrangement of the Ig locus (Hardy and
Hayakawa, 2001). Expression and signaling from the
pre-BCR mediates the progression of developing B cells,
first into large (cycling) pre-B1 cells and then into small
pre-B2 cells in which light-chain rearrangement occurs.
The pre-B1-to-pre-B2 transition is marked not only by
a change in cell size but by changes in the display of cell
surface markers such as CD43, c-Kit, CD2, pre-BCR,
and CD25 (IL-2R) (Hardy and Hayakawa, 2001). By com-
paring the display of cell surface markers on wild-type
and Oca-b/ bone-marrow B cells, we have found that
Oca-b/ mice have a partial block in the pre-B1-to-pre-
B2 stage of B cell development. This defect is similar to
that observed in mice deficient inBtk, Slp-65, or interferon
regulatory transcription factors Irf4 and Irf8 (reviewed in
Hendriks and Middendorp, 2004). More importantly, this
type of block, although more severe, has also been de-
scribed in Syk/ mice (Cheng et al., 1995; Turner et al.,
1995; Saijo et al., 2003).
OCA-B is known to play a role in BCR signaling, as evi-
denced by studies showing that Oca-b/ cells have re-
duced responsiveness to this signaling pathway (Kim
et al., 1996), and this could be due in part to the OCA-B-
SYK interaction. Additionally, many of the OCA-B target
genes (such as Lck, Cyclin D3, Cdc37, and Kcnn4) that
are induced by BCR stimulation have now been shown
to be expressed in pre-B cells. With this in mind, it seemed
likely that the newly identified developmental block could
be due to the role of OCA-B in pre-BCR signaling. In mice,
IL-7-mediated signaling promotes cellular proliferation
and survival of IL-7Ra-bearing B cells (Rolink et al.,
1991; Ray et al., 1998). Highly relevant to this study, it is
suspected that pre-BCR signaling eventually leads to
the termination of IL-7-induced proliferation via an SLP-
65-BTK-dependent pathway (Marshall et al., 1998; Flem-
ing and Paige, 2002).
As reported forBtk/ andSlp-65/ cells in the IL-7 cul-
ture system (Middendorp et al., 2002; Flemming et al.,
2003), we have found Oca-b/ and Syk/ cells to be
markedly hyperproliferative in the presence of IL-7. Addi-
tionally, we have shown that there is a substantial increase
in and persistence of pre-BCR+ cells within the Oca-b/Cell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc. 769
Figure 6. Analysis and Characterization of the OCA-B-SYK Interaction
(A) Oca-b+/+ splenic B cells were activated in culture with anti-IgM for a time course from t = 0 to 5 hr. Immunoprecipitation (IP) was performed using
anti-OCA-B or IgG (control) and whole-cell extract (WCE). The presence of SYK in the IP was monitored by immunoblotting. The total level of SYK,
ERK, and tyrosine-phosphorylated proteins (pTYR) in the WCE was also examined.
(B)Oca-b+/+ splenic B cells were activated in culture with anti-IgM, anti-CD40, and IL-4. IP of OCA-B or SYK fromWCEwas detected by immunoblot.
The total protein level is shown for OCA-B and ERK (bottom panels). Each IP experiment was reproduced at least four times.
(C) Coomassie blue-stained SDS gel showing purified GST or GST-OCA-B proteins (products marked by arrows).
(D) Purified His-tagged SYK was incubated with immobilized GST or GST-OCA-B proteins, and bound SYK was monitored by immunoblotting. This
experiment was performed at least three times.
(E) Purified His-tagged SYK or Ni-NTA beads alone (control) were incubated with Namalwa cellular extracts. The binding of OCA-B was monitored by
immunoblotting. Long and short exposures are shown to distinguish OCA-B p34 and p35. This experiment was reproduced five times.
(F) WCE from Namalwa cells that were stimulated with anti-IgM for a time course was used for IP with anti-OCA-B. The presence of SYK and tyrosine-
phosphorylated proteins (pTYR) in the WCE and IP were analyzed by immunoblot, and the band that corresponds to phosphorylated SYK is labeled.
This experiment was performed twice.770 Cell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc.
Figure 7. Rescue of Oca-b/ Mice with
OCA-B Transgenes
(A) CD19+ B cells were isolated from bone
marrow of Oca-b+/+ (Oca-b/ with wild-type
Oca-b transgene), p34+/+ (Oca-b/ with
p34-Oca-b transgene), p35+/+ (Oca-b/ with
p35-Oca-b transgene), or Oca-b/ (no trans-
gene) mice, and the experiment was carried
out as in Figure 2A.
(B) WCE was prepared from CD19+ bone-mar-
row B cells that had been cultured in IL-7 for
48 hr. The restoration of SYK protein stability
in transgenic mice was monitored by immuno-
blot. This experiment was performed twice.culture. This finding not only mimics the phenotype ob-
served in vivo but further suggests that there is a buildup
of these cells due to inefficient mediation of IL-7Ra signal-
ingby thepre-BCR in thedeficient cells. Asmentionedpre-
viously, another major outcome of pre-BCR signaling is to
promote Ig light-chain rearrangement, which, if success-
ful, is followed bydisplay of thematureBCRon the cell sur-
face; SYK exerts amajor function in this signaling process,
which is defective in theOca-b/ cells. Furthermore, pre-
BCR signaling mediates downregulation of the surrogate
light-chain genes Vpre-b and l5 in pre-B2 cells (reviewed
in Hendriks and Middendorp, 2004). Overexpression of
these genes inOca-b/ pre-B2 cells further indicates de-
fective pre-BCR signaling. The finding that Oca-b/ and
Syk/ mice have similar defects in early B cell develop-
ment and proliferation suggests that OCA-B is an impor-
tant factor in pre-B cell signaling through SYK and empha-
sizes the importance of the OCA-B-SYK interaction.
OCA-B-SYK Interaction in Antigen-Dependent
B Cell Differentiation
A severe reduction in the SYK protein level is also ob-
served in OCA-B-deficient splenic B cells and can be di-
rectly attributed to reduced SYK stability in Oca-b/
cells. The SYK protein level is reduced more quickly,
and to a greater extent, in Oca-b/ cells that have been
activated in culture. Oca-b/ mice display both a signifi-cant reduction in follicular B cells and a general reduction
of peripheral B cells (Schubart et al., 1996; Kim et al.,
2000). Interestingly, while Syk/ mice can accumulate
immature B cells in the periphery, they fail to enter follicles
or the recirculating B cell pool (Turner et al., 1997). There-
fore, it is possible that the reduced stability and resulting
decrease of the SYK protein level inOca-b/ B cells con-
tributes to the decrease in follicular and recirculating B
cells in Oca-b/ mice. In the case of costimulation to
mimic T cell-dependent activation, wild-type cells show
a reduction in SYK by 65 hr. This change correlates with
differentiation of these cells, as evidenced in part by in-
creased IgG1 transcription (Kim et al., 2003). The more
dramatic reduction of SYK protein levels in the Oca-b/
cells may contribute to the compromised antigen-depen-
dent immune response of Oca-b/ mice.
Mechanism of OCA-B-SYK Interaction
The deduced mechanism by which OCA-B regulates SYK
protein levels is surprising since SYK is not a transcrip-
tional target of OCA-B on the basis of qPCR and chroma-
tin immunoprecipitation assays. Because of this, alterna-
tive functions of OCA-B, both direct and indirect, must
be considered. Themost obvious evidence to support a di-
rect effect of OCA-B onSYKprotein stability is that the two
proteins strongly interact, as shown in vitro by assays with
bacterially expressed (unmodified) forms at high salt(G) Purified His-tagged SYK proteins were incubated with S100 from Namalwa cells. The binding of OCA-B was monitored by immunoblotting. SH2-
L = SH2 domains and linker domain, SH2 =SH2 domains alone, L = linker domain, LK = linker domain and kinase domain, and LKD = truncations of the
linker-kinase construct. This experiment was performed twice.Cell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc. 771
concentrations and in vivo by coimmunoprecipitation.
Also, SYK is heavily regulated at the protein level by ubiq-
uitin-mediated degradation by CBL, a RING-finger ubiqui-
tin ligase that binds to SYK that has been tyrosine phos-
phorylated in its linker region (residue 317) (reviewed in
Rao et al., 2002). Importantly, we have demonstrated
that SYK stability is reduced and that SYK phosphorylated
at residue 317 is increased in Oca-b/ mature B cells
stimulated by anti-IgM. This increase in phosphorylated
SYK and the decrease in total SYK levels due to SYK in-
stability in the Oca-b/ cells may reflect an inability of
OCA-B to interact with and stabilize SYK. This stabilization
most likely affects the inactive form of SYK because OCA-
B interacts with unphosphorylated SYK through its kinase
domain. This would represent a unique and novel mecha-
nism by which SYK protein levels are maintained for acti-
vation upon BCR stimulation.
Another interesting aspect of the interaction between
SYK and OCA-B is that the interaction increases upon
BCR signaling and can occur with either form of OCA-B.
Consistent with the finding that the OCA-B C terminus,
which is constant in both forms of OCA-B, is most impor-
tant for interaction with SYK, pull-down and immunopre-
cipitation assays showed that SYK can interact with
both the myristoylated p35 and p34 forms of OCA-B while
rescue experiments in Oca-b/ mice showed that both
forms of OCA-B are able to stabilize SYK in vivo and res-
cue the IL-7 hyperproliferation defect. Additionally, immu-
nofluorescence analyses show colocalization of OCA-B
and SYK in Namalwa cells following stimulation by anti-
IgM or costimulation with anti-IgM, anti-CD40, and IL-4.
The Namalwa cells show responsiveness to BCR signaling
in that IgM becomesmore aggregated with treatment. The
significantly increased incidence of cells with ‘‘nuclear ex-
clusion’’ of OCA-B following BCR stimulation is likely to be
related to its interaction with SYK because increased as-
sociation between OCA-B and SYK is detected by immu-
noprecipitation using extracts from these cells. Possibly
related to this idea, there is also a fraction of cells that
have strong nuclear staining for SYK. Nuclear localization
of SYK has been reported previously and is dependent on
a nuclear localization signal in the linker region (Ma et al.,
2001; Wang et al., 2003), although the functional signifi-
cance of this finding has not been fully determined. Further
investigation into the translocation of OCA-B within the
cell could provide yet another example of the unique be-
havior of this transcriptional cofactor and could also reveal
alternative functions for SYK.
Dual Function of OCA-B in B Cell Signaling
Although OCA-B is best known for its function as a tran-
scription coactivator (Luo and Roeder, 1999), this study
provides further evidence that OCA-B can function by
multiple mechanisms within the cell. As a transcription
factor, OCA-B activates a subset of genes that are impor-
tant in cell signaling (Kim et al., 2003). Although there is
also a severe reduction in LCK RNA and protein levels in
Oca-b/ pre-B cells, Lck/ mice display a normal pre-772 Cell 125, 761–774, May 19, 2006 ª2006 Elsevier Inc.B1-to-pre-B2 transition and grow normally in an IL-7 cul-
ture (data not shown). Therefore, the reduction in LCK is
not likely to be responsible for the defects in pre-B cell dif-
ferentiation in Oca-b/ mice. However, regulation of
OCA-B target genes has been shown to be important for
other aspects of B cell differentiation—in particular, ma-
ture B cell function (Teitell, 2003). Interestingly, the OCA-
B-SYK interaction occurs early during B cell activation,
when OCA-B expression is relatively low. When OCA-B
expression is at the highest level, later in the activation
program, not only is the OCA-B-SYK interaction no longer
apparent, but the transcriptional targets of OCA-B start to
be induced (Figure 6 and Kim et al., 2003). These findings
indicate that OCA-B plays dual roles in the cell, making it
broadly important for B cell signaling. Not only can it
regulate early events in intracellular signaling by direct in-
teraction with signaling components (SYK), it can also
function classically as a transcription coactivator on
downstream target genes at later stages of B cell activa-
tion.
EXPERIMENTAL PROCEDURES
Animals
Eight- to ten-week-old female Oca-b/ mice (Kim et al., 1996) and
C57BL/6J mice were used for all experiments. Syk conditional knock-
out mice were also used (Syk/) (Saijo et al., 2003). All mice were
maintained under specific-pathogen-free conditions at the Laboratory
Animal Research Center at The Rockefeller University.
Flow Cytometry Analysis and Cell Sorting
Bone-marrow cells were flushed from the femurs and tibia of 5–8 mice
using PBS. Cell suspensions were prepared for staining according to
standard procedures (Kim et al., 2000). Cell surface markers were
detected using the following antibodies (all from BD PharMingen):
B220-PE, CD43-FITC, CD117-APC, IgM-APC, CD19-PE, CD25-APC,
IgD-PE, pre-BCR (clone SL-156) streptavidin-PE, and k-PE. For size
analysis, large cells were gated (FSC-H > 375) and the percentages
obtained were used in a Student’s t test to determine statistical signif-
icance. For sorting, total bone-marrow cells from 10–12 female mice
were isolated and sorted based on staining using the FACS Vantage
SE (BD Biosciences). Dead cells and doublets were excluded on the
basis of propidium-iodide incorporation and laser scatter patterns, re-
spectively. Postsort analysis was performed to access the purity of all
the fractions collected.
RT-PCR and qPCR
RT-PCR was carried out according to standard protocols using cycle
numbers within the linear range of amplification for each gene, as de-
termined by qPCR (Kim et al., 2003). qPCR was performed as de-
scribed (Kim et al., 2003), with minor modifications. For these experi-
ments, the reference gene was Gapdh, although similar results were
obtained using the gene encoding the RBP5 subunit of RNA polymer-
ase II.
Primary B Cell Culture
CD19+ B cells from bone marrow were isolated by MACS (Miltenyi Bi-
otec) and cultured without feeder cells using RPMI supplemented with
20%FBS, 0.05mM b-ME, 100 U/ml P/S, and 5 ng/ml recombinant IL-7
(Sigma). Fresh IL-7 was added every 72 hr. Flow cytometry was per-
formed as above. Splenocytes were harvested and B cells were en-
riched bycomplement-mediated lysis of Thy-1+ cells followedbyaPer-
coll gradient either to separate dead cells and debris or to fractionate
resting B cells (Figure 4G). Preparations were determined to contain
at least 92% live B220+ cells by flow cytometry. The cells were stimu-
lated as described previously (Kim et al., 2003). To analyze protein
stability, cycloheximide was added at a concentration of 10 mg/ml.
Pre-BCR Crosslinking and Immunoblotting
CD19+ cells were cultured in IL-7-containing media for 48 hr. Cultures
were then depleted of Igk+ cells using biotinylated anti-k (BD Pharmin-
gen) conjugated to streptavidin Dynabeads (Dynal Biotech). Depleted
fractions were washed and cultured for 4 hr without serum and IL-7
and then stimulated at 37ºC with 10 mg/ml anti-IgM F(ab0)2 (Pierce Bio-
technology). The cells were washed with PBS/1 mMNa3VO4 and lysed
withNP40/vanadate buffer (1.5%NP40, 1mMPMSF, 1mMNaF, 1mM
Na3VO4, and 20 mM leupeptin). Tyrosine phosphorylation was ac-
cessed using anti-phosphotyrosine (4G10, Upstate Biotechnology).
Blots were stripped and then probed with antibodies (all from Santa
Cruz Biotechnology) to OCA-B (C-20), SYK (N-19), LCK (sc-13), FYN
(fyn3), ERK (C-14), phospho-SYK (Tyr317) (Cell Signaling Technolo-
gies), or actin (Sigma).
Protein-Protein Interaction Studies
For immunoprecipitation, lysates were incubated with anti-OCA-B,
anti-SYK, or rabbit IgG (control) for 2 hr followed by incubation with
protein A Sepharose (Amersham). The immunoprecipitate was then
washed four times with lysis buffer, resolved by SDS-PAGE, and ana-
lyzed by immunoblot. cDNAs encoding OCA-B residues 1–256, 1–154,
and 154–256 or SYK 1–629 were inserted into the GX41 or PET28a
plasmids, respectively. The proteins were expressed and purified
from E. coli according to standard procedures. For the GST-protein-
protein interaction experiments, 10 mg of GST-OCA-B protein was
bound to glutathione Sepharose (Amersham) and incubated with ap-
proximately 250 ng of purified His6-tagged SYK for 3 hr at 4ºC. The
beads were washed six times with binding buffer (20 mM Tris-HCl
[pH 7.4], 20% glycerol, 0.2 mM EDTA, 0.1% NP40, 0.2 mM PMSF,
and 400 mM KCl). The bound proteins were resolved by SDS-PAGE
and analyzed by immunoblot. For the Ni-NTA pull-down experiments,
10 mg of purified His-tagged SYKwas incubated with extracts fromNa-
malwa cells for 3 hr in binding buffer (20 mM Tris-HCl [pH 7.4], 10%
glycerol, 30 mM imidazole, 0.1% NP40, 1.0 mM PMSF, 0.2 mg/ml
BSA, and 150 mM NaCl). The beads were washed six times with bind-
ing buffer, and bound proteins were resolved by SDS-PAGE and ana-
lyzed by immunoblotting. Cytoplasmic and nuclear extracts were pre-
pared according to standard procedures (Dignam et al., 1983).
Immunofluorescence Microscopy
Namalwa cells were treated with goat anti-human IgM F(ab0 )2 (South-
ern Biotechnology) or with anti-human IgM F(ab0)2, anti-human CD40,
and recombinant human IL-4 for various lengths of time before fixation
with 2% PFA. Cells were permeabilized using 0.5% saponin and incu-
bated with anti-SYK (4D10) and/or anti-OCA-B (C-20) (Santa Cruz Bio-
technology). The secondary antibodies used were Alexa Fluor 488-
conjugated chicken anti-rabbit IgG, Alexa Fluor 488-conjugated
chicken anti-mouse IgG, Alexa Fluor 546-conjugated goat anti-rabbit
IgG, and Alexa Fluor 546-conjugated donkey anti-goat IgG.
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